"
Team:Macquarie Australia/Safety
From 2012.igem.org
| Line 1: | Line 1: | ||
{{:Team:Macquarie_Australia/Template/MQ12}} | {{:Team:Macquarie_Australia/Template/MQ12}} | ||
| - | + | ==Safety== | |
Revision as of 03:23, 21 August 2012
Safety
Use this page to answer the questions on the safety page.
1. Would any of your project ideas raise safety issues in terms of:
The safety and health of the team
Due to the nature of laboratory work there is always a certain level of risk involved when undertaking a research project. All possible precautions regarding possible safety issues were addressed prior to the beginning of the experimental work for iGem. Members of the project team have undergone a number of safety inductions including a laboratory training course, in conjunction to standard university occupational health and safety training. The bacterial strains used in this project were considered non-hazardous and non-infectious. Culture volumes were also kept to a minimum to ensure the risk of spread was minimised. While the bacteria were transformed with bacterial plasmids carrying the desired gene and antibiotic resistance required for selection. This antibiotic resistance is commonly used in laboratories (such as ampicillin, chlorampheniol and kanamycin) and do not interfere with potential clinical treatment. All student members were supervised in the laboratory when using lab equipment or carrying out lab procedures. Use of Personal Protective Equipment (PPE) was employed including lab coats, gloves, appropriate foot wear and safety goggles.
The safety of the general public by design or accident
To ensure the safety of the general public no materials used for the project were exposed to the public or the environment. Also as none of the organisms used are pathogenic, they do not pose a risk to human health even if accidently released.
Environmental quality if released by design or accident.
To ensure that none of the products were potentially hazardous to the environment all materials and biological wastes were sterilized in the autoclave prior to disposal. A material Safety Data Sheet was completed for all chemicals and reagents used and disposed of according to safety regulations.
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes were these documented with the registry and how were these concerns managed?
The Bacteriophytochrome gene is a pigment-binding protein and the Heme Oxygenase gene is a metabolic enzyme, and have no toxic or pathogenic risk factors associated with them. The E.coli strains used are classified as ‘Exempt Dealings’ under the Gene Technology Act, as they are either E.coli K12 or B derived (BL21 (DE3)) and are not considered to be pathogenic or hazardous. Due to this the safety concerns did not have to be documented with the parts registry and no additional precautions needed to be taken.
3. Is there a local biosafety group, committee, or review board at your institution?
Macquarie University has Biosafety committee who ensures that the university complies with the requirements of the Australian Governments legislation: Gene Technology Act, 2000. The iGem project was granted an ‘Exempt Dealing’ (REF:5201001087EX) for the expression of proteins involved in biosynthesis of photosynthetic and non-photosynthetic organisms. More information on the legislations involved with the Australian Government's Gene Technology Regulator can be found here
</p>
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
Our research team were given a talk in a laboratory safety talk regarding how to follow general safety protocol in a laboratory setting. As the iGem competition is a way of collaborating and sharing information the jamboree could also be used as a medium for which safety protocols specifically designed for the iGem project can be discussed and presented. This would be especially effective due to the international nature of the competition, thus allowing for the collaboration of safety protocols that are implements in laboratories across the world. </html>
